dabigatran etexilate

Known as: Etexilate, Dabigatran, Ethyl 3-(((2-(((4- ((((hexyloxy)carbonyl)amino)iminomethyl)phenyl)amino)methyl)-1-methyl-1H-benzimidazol-5-yl)carbonyl)(pyridin-2- yl)amino)propanoate, Ethyl 3-[[[4-[[[(hexyloxyl)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl](pyridin-2-yl)amino] propanoate 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Due to low bioavailability and high inter-individual variability, monitoring of dabigatran may be required in specific situations… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2011
Review
2011
Dabigatran Etexilate: A New Oral Thrombin Inhibitor Print ISSN: 0009-7322. Online ISSN: 1524-4539 Copyright © 2011 American Heart… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2010
Review
2010
Dabigatran etexilate is an oral, reversible direct thrombin inhibitor that is approved in the EU and several other countries for… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Dabigatran etexilate is an oral direct thrombin inhibitor in clinical development for the prevention and treatment of… (More)
Is this relevant?
Review
2009
Review
2009
Dabigatran etexilate is a novel, oral reversible direct thrombin inhibitor that is rapidly absorbed and converted to its active… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Dabigatran, an oral once-daily unmonitored thrombin inhibitor, has been tested elsewhere using enoxaparin 40 mg once daily. We… (More)
Is this relevant?
Review
2008
Review
2008
The direct thrombin inhibitor dabigatran etexilate is currently in phase III of development for the prophylaxis and treatment of… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND After hip replacement surgery, prophylaxis following discharge from hospital is recommended to reduce the risk of… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2007
Highly Cited
2007
AIMS The novel direct thrombin inhibitor (DTI), dabigatran etexilate (Boehringer Ingelheim Pharma GmbH & Co. KG), shows potential… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND Oral anticoagulants, such as dabigatran etexilate, an oral, direct thrombin inhibitor, that do not require monitoring… (More)
Is this relevant?